KA/EN
Register
Medicines reference
Search
Search
Product

Biocan Novel DHPPi/L4

Favourites

Canine distemper virus + Canine adenovirus + Canine parvovirus + Canine parainfluenza virus + Leptospira icterohaemorrhagiae + Leptospira canicola + Leptospira grippotyphosa + Leptospira australis · Bioveta, a.s.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml (1 ml)
Aseptically reconstitute, shake and immediately inject the entire 1 ml dose subcutaneously. Primary series: two doses 3-4 weeks apart from 6 weeks of age. Core revaccination every 3 years; annual CPiV/L4 revaccination is required. Vaccinate healthy dogs only. Do not use with hypersensitivity to the adjuvant or excipients. Maternal antibodies can delay response. Vaccinated dogs may shed live CAV-2, CPiV and CPV-2b; separate from susceptible non-dog carnivores and cats as a precaution. Not recommended during pregnancy or lactation. Common transient injection-site swelling; rare gastrointestinal or hypersensitivity reactions require prompt symptomatic treatment. Use with other medicines case by case; do not mix. Store 2-8 C, do not freeze, protect from light and use immediately after reconstitution.
 · two doses 3-4 weeks apart; core every 3 years and Pi/L4 annually		 two doses 3-4 weeks apart; core every 3 years and Pi/L4 annually Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ბიოკან ნოველ DHPPi/L4
№ 151-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Biocan Novel DHPPi/L4, Suspension

lyophilisate and suspension, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.4/10
Very good
vetman assessment

Biocan Novel DHPPi/L4

lyophilisate and suspension, 1 ml dose for dogs
Assessed clinical scopeDog · Full dog label from 6 weeks: core CDV, CAV-1/2 and CPV protection plus CPiV and four-serogroup leptospirosis immunisation · Subcutaneous
Care settingPreventive veterinary vaccination of a healthy dog with examination, cold-chain control and emergency treatment available
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 151-11 · Verified on 21 Oct 2026

A very good, transparent all-in-one puppy and adult vaccine combining long-duration core protection with four-serogroup leptospirosis cover. The two-dose label minimum must still fit a puppy programme that finishes the core series at 16 weeks or later when maternal antibody is likely.

Regulatory and scientific credibility9.0/10

The exact presentation is registered in Georgia (151-11) and has a current EU national authorisation with a detailed SPC giving strains, potency, onset and duration of immunity.

Clinical efficacy8.5/10

Live CDV, CAV and CPV core components have strong consensus support and a labelled three-year duration; the four-serogroup leptospiral fraction includes Australis and matches current ACVIM advice, while CPiV and Leptospira need annual boosting.

Safety and tolerability8.0/10

Benefit-risk is favourable in healthy dogs: transient injection-site swelling up to 5 cm is common, gastrointestinal or hypersensitivity reactions are rare, and live-strain shedding plus pregnancy restrictions need attention.

Clinical practicality8.0/10

One fixed 1 ml subcutaneous dose and three-yearly core revaccination are practical; reconstitution, immediate use, the cold chain and a separate annual Pi/L4 dose add manageable clinic work.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use with hypersensitivity to the aluminium hydroxide adjuvant or an excipient. Vaccinate clinically healthy dogs only.
  • Maternal antibody can delay the CDV, CAV and CPV response. Fit the two-dose label course into a puppy series whose last core dose is given at 16 weeks or later when maternal antibody is likely.
  • Core components last at least three years, but CPiV and the four leptospiral serogroups last one year: give an annual Pi/L4 or equivalent booster where the risk persists.
  • Safety in pregnancy and lactation is not established and use is not recommended.
  • Vaccinated dogs can shed live CAV-2, CPiV and CPV-2b strains. Keep vaccinated dogs away from cats and other susceptible carnivores for a period and dispose of faeces hygienically.
  • Transient injection-site swelling up to 5 cm is common and settles within 14 days; rare vomiting, diarrhoea, anorexia, lethargy or hypersensitivity needs observation and prompt symptomatic treatment.
  • No data support giving it with other veterinary medicines; decide timing case by case and do not mix with other products.
  • Store at 2-8 C, do not freeze, protect from light and inject the whole reconstituted 1 ml immediately.
Assessment sources
  1. EU UPD SPC 20262026
  2. Georgia NFA register 20262026
  3. WSAVA vaccination 20242024
  4. ACVIM leptospirosis consensus 20232023
  5. AAHA canine vaccination 20222022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine distemper virus3.1 log10 TCID50/dose Canine adenovirus3.6 log10 TCID50/dose Canine parvovirus4.3 log10 TCID50/dose Canine parainfluenza virus3.1 log10 TCID50/dose Leptospira icterohaemorrhagiae375 EU/dose Leptospira canicola375 EU/dose Leptospira grippotyphosa375 EU/dose Leptospira australis375 EU/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Bioveta, a.s. · Czechia
Manufacturer (register)
Bioveta a.s., Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 446, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ბიოკან ნოველ DHPPi/L4
№ 151-11
Verified on: 21 Oct 2026
 EU Yes, veterinary
№ BG 0022-2377
Verified on: 23 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml (1 ml)
Aseptically reconstitute, shake and immediately inject the entire 1 ml dose subcutaneously. Primary series: two doses 3-4 weeks apart from 6 weeks of age. Core revaccination every 3 years; annual CPiV/L4 revaccination is required. Vaccinate healthy dogs only. Do not use with hypersensitivity to the adjuvant or excipients. Maternal antibodies can delay response. Vaccinated dogs may shed live CAV-2, CPiV and CPV-2b; separate from susceptible non-dog carnivores and cats as a precaution. Not recommended during pregnancy or lactation. Common transient injection-site swelling; rare gastrointestinal or hypersensitivity reactions require prompt symptomatic treatment. Use with other medicines case by case; do not mix. Store 2-8 C, do not freeze, protect from light and use immediately after reconstitution.
 Dog Any weight Subcutaneous two doses 3-4 weeks apart; core every 3 years and Pi/L4 annually
EU UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Biocan Novel DHPPi/L4 - official product information
EU Union Product Database, 2026

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine adenovirus: No dose supported by a publicly verifiable source yet

Canine parvovirus: No dose supported by a publicly verifiable source yet

Canine parainfluenza virus: No dose supported by a publicly verifiable source yet

Leptospira icterohaemorrhagiae: No dose supported by a publicly verifiable source yet

Leptospira canicola: No dose supported by a publicly verifiable source yet

Leptospira grippotyphosa: No dose supported by a publicly verifiable source yet

Leptospira australis: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (1 more) Hide additional products

Same product line 1

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗